About
Decitabine is a hypomethylating agent primarily used in the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). It functions by inhibiting DNA methyltransferase, an enzyme crucial for DNA methylation. This inhibition leads to hypomethylation of DNA, which can reactivate silenced tumor suppressor genes and induce differentiation and apoptosis in malignant cells. By restoring normal gene expression patterns, Decitabine helps to correct the abnormal proliferation and differentiation of hematopoietic stem cells characteristic of these conditions.
Its mechanism of action helps to restore normal cell growth and differentiation, making it a valuable therapeutic option for patients with these hematological malignancies who may not be candidates for intensive chemotherapy. The goal of treatment with Decitabine is to improve blood counts, reduce transfusion dependence, and potentially prolong survival, thereby enhancing the quality of life for patients by mitigating disease-related symptoms and progression.
Uses
- Myelodysplastic syndromes (MDS)
- Acute myeloid leukemia (AML)
- Chronic myelomonocytic leukemia (CMML)
- Certain other hematological malignancies
Directions For Use
Administered intravenously by a qualified healthcare professional. Dosage and duration are determined by the specific condition and patient response.
Benefits
- Induces remission in MDS and AML
- Improves blood counts and reduces transfusion dependence
- Prolongs survival in some patient populations
- Targets cancer cells by epigenetic modification
- Relatively well-tolerated compared to intensive chemotherapy
- Can improve quality of life for patients
Side Effects
- Myelosuppression (anemia, neutropenia, thrombocytopenia)
- Fatigue and weakness
- Nausea and vomiting
- Diarrhea or constipation
- Fever and chills
- Headache
- Peripheral edema
- Rash or skin reactions
- Mucositis (inflammation of mucous membranes)
- Injection site reactions
- Loss of appetite
- Dizziness
Safety Measures
- Alcohol - Avoid or limit alcohol due to potential for increased gastrointestinal irritation and liver strain during treatment.
- Pregnancy - Contraindicated during pregnancy due to significant risk of fetal harm. Effective contraception is essential for both men and women.
- Breastfeeding - Contraindicated. The drug may pass into breast milk and potentially harm the infant. Do not breastfeed during treatment.
- Liver - Use with caution in patients with hepatic impairment; monitor liver function closely and adjust dosage if necessary.
- Kidney - Use with caution in patients with renal impairment; dosage adjustment may be necessary. Monitor kidney function regularly.
- Lung - Monitor for pulmonary toxicity, though less common. Report any new or worsening respiratory symptoms promptly to your doctor.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |

No comments found for this product. Be the first to comment!